Skip to content

EGD-assisted Bowel Preparation for Colonoscopy

EGD-assisted Bowel Preparation for Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01563744
Enrollment
82
Registered
2012-03-27
Start date
2009-08-31
Completion date
2012-03-31
Last updated
2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy, Esophagoscopy Techniques

Keywords

colonoscopy, bowel preparation, tolerability, EGD-assisted

Brief summary

Adequate bowel preparation is of critical importance for colonoscopy. Particularly among hospitalized patients, inadequate bowel preparation for colonoscopy may arise due to patient intolerance to prescribed laxative regimen, elderly population, and co-existing conditions that impair the ability to ingest a large-volume laxative regimen. Improvements in bowel preparation for colonoscopy in hospitalized patients would likely improve patient care and reduce hospital costs. The purpose of this study is to determine if administering a portion of the bowel purgative via EGD could improve colonoscopy preparation in hospitalized patients.

Detailed description

In this randomized controlled trial in hospitalized patients, patients in whom colonoscopy was anticipated the day following EGD were consented and randomized to either standard prep by mouth (split-dose PEG) or intervention group (instillation of the first 2 liters of Nulytely solution through the channel of the endoscope into the duodenal bulb, then continue standard prep). Data is collected on quality of prep and patient satisfaction in both groups.

Interventions

PROCEDUREEGD-assisted administration of colonoscopy prep

Interventional group receive the first 2 liters of prep solution during EGD through the scope channel if colonoscopy expected the following day.

PROCEDUREControl Group received standard prep by oral administration

Control group receive standard oral colonoscopy prep.

Sponsors

Rockford Gastroenterology Associates
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* hospitalized patients * having EGD and expected to have colonoscopy the following day * written informed consent

Exclusion criteria

* unable to tolerate EGD-assisted prep administration

Design outcomes

Primary

MeasureTime frameDescription
Quality of bowel preparationTwenty four to 48 hours - from time of consent prior to EGD until end of colonoscopy performed the following dayQuality of prep was assessed using the Ottawa bowel preparation scale (Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest endosc 2004;59:482-6)

Secondary

MeasureTime frameDescription
Patient tolerance of bowel preparationadministered just prior to sedation for colonoscopyPatients in both groups were asked to indicate if the bowel prep was easy, slightly difficult, moderately difficult, extremely difficult, or if they were unable to complete the prep as directed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026